BridgeBio is hoping infigratinib will get another shot at approval after the medicine hit the key goals of a phase 3 study in a form of dwarfism in children. The FDA granted infigratinib, which was ...
Add Yahoo as a preferred source to see more of our stories on Google. October is a month of recognition for many in Erie and beyond. For 65,000 people in the nation born with dwarfism, the month ...
A BridgeBio Pharma drug developed for dwarfism increased children’s growth rates in a pivotal clinical trial, meeting the study’s main goal and boosting the daily pill’s chances to offer an ...
Julie Wyman explores her place in the community of little people in the new PBS documentary 'The Tallest Dwarf' PBS Filmmaker Julie Wyman, who says she inherited “short arms and legs, and a long torso ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results